2-Thiazolylethylamine, a selective histamine H1 agonist, decreases seizure susceptibility in mice
- 31 March 1994
- journal article
- Published by Elsevier in Pharmacology Biochemistry and Behavior
- Vol. 47 (3) , 503-507
- https://doi.org/10.1016/0091-3057(94)90151-1
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Effect of thioperamide, a histamine H3 receptor antagonist, on electrically induced convulsions in miceEuropean Journal of Pharmacology, 1993
- Histamine H1 receptors in complex partial seizuresThe Lancet, 1993
- Effect of Histamine on Memory Retrieval in Old Rats.Biological & Pharmaceutical Bulletin, 1993
- Histaminergic modulation and chemically-induced seizures in miceInflammation Research, 1992
- Histamine in brain — its role in regulation of seizure susceptibilityEpilepsy Research, 1991
- Is the histaminergic neuron system a regulatory center for whole-brain activity?Trends in Neurosciences, 1991
- Pharmacological characteristics of catalepsy induced by intracerebroventricular administration of histamine in mice: The importance of muscarinic step in central cholinergic neuronsInflammation Research, 1991
- Effects of intracerebroventricular histamine injection on circadian activity phase entrainment during rapid illumination changesNeuroscience Letters, 1991
- Highly potent and selective ligands for histamine H3-receptorsNature, 1987
- Is histamine an anticonvulsive inhibitory transmitter?Neuropharmacology, 1986